Challenges and Barriers to 503B Compounding

Zepbound from Eli Lilly is the first and only prescription medicine approved by the FDA for adults with obstructive sleep apnea and obesity.

Drug Topics sat down with Laird Leavoy, President of American Pharmacies, to discuss the role leadership plays in the independent pharmacy industry.

Although the drug fell short of its 25% expected weight loss, results are still promising for people with overweight or obesity.

Tom Utech, PharmD, CEO of iA, joined Drug Topics to discuss his company’s centralized pharmacy fulfillment solutions.

Recent upticks of the bird flu virus in both dairy cattle and humans have also led to a state of emergency in California.

The lawsuit alleges that the company knowingly violated both the Controlled Substances Act and the False Claims Act.